THIER Strengthens Leadership with Appointment of Ian Dalton as Independent Non-Executive Director
THIER Strengthens Leadership with Appointment of Ian Dalton as Independent Non-Executive Director 🚀
[City, Date] – THIER, a digital health start-up dedicated to preventing lifestyle-related diseases, is pleased to announce that Ian Dalton has joined its Board of Directors as an Independent Non-Executive Director, effective September 25, 2024. Ian’s appointment reflects THIER’s commitment to delivering innovative, data-driven health solutions that empower organisations to support employee wellness and prevent lifestyle diseases.
Ian Dalton brings a distinguished career spanning over 30 years in software delivery 💻, product development, and operational strategy, with a particular emphasis on SaaS solutions and bespoke software innovations. He has held key executive roles, including Chief Operating Officer, Group Operations Director, VP of Professional Services, and Head of Consulting, where he led large-scale, cross-functional teams through complex product development and operational roll-outs. Ian’s expertise in Agile methodologies 🛠️ and iterative development cycles has enabled him to accelerate product launches and enhance time-to-market efficiency, maximising value delivery for clients.
Ian’s data-driven approach, honed in leadership positions at renowned SaaS companies like Omnico and Software of Excellence, has been instrumental in refining product features and ensuring value delivery. His extensive knowledge in utilising data and analytics to inform product development has distinguished his previous organisations and aligns perfectly with THIER’s mission to offer cutting-edge health solutions.
Kofo Mary Are, Founder of THIER, shared her excitement about Ian’s addition to the board:
"We are delighted to welcome Ian Dalton to the THIER Board. Ian’s wealth of experience in software innovation and operational strategy will be invaluable as we strengthen our platform’s capabilities and expand our reach in the digital health space. His insights will support our mission to deliver effective, AI-driven health solutions that make a real difference in people’s lives." 🌟
Ian Dalton shared:
"I am excited to join THIER’s Board at such a pivotal time. I look forward to working with the team to bring innovative, data-informed health solutions to market and contribute to the company’s growth journey." 🤝
About THIER
THIER is an AI-driven mobile platform 🤖📱 focused on preventing obesity and type II diabetes by offering tools to enhance employee wellness 🏋️♀️ in mid-tier and large organisations across diverse industries, including:
- Manufacturing 🏭
- Healthcare 🏥
- Technology 💻
- Financial Services 💰
- Energy ⚡
- Transportation 🚛
THIER provides Heads of Wellness, HR, and Occupational Health with resources to identify, track, and prevent the onset of lifestyle diseases within their workforce communities.
Through advanced machine learning algorithms 🧠, community support 🤝, and customised health interventions from preventive healthcare experts 🩺, THIER’s platform promotes proactive health management. All data is securely stored on the blockchain 🔒, ensuring robust data security and privacy.
Discover more about THIER’s transformative approach:
- 🎥 Watch our introductory video: [Link to Video]
🤝 Interested in supporting early-stage digital health innovation as an investor? Connect with us here: 👈 😀
💡 Note: THIER holds SEIS and EIS assurance, offering tax benefits for investors.
For further information, please contact:
📧 THIER Communications Team: Press@thier.io
***********
The information in this announcement may include forward-looking statements, which are based on the current expectations and projections about future events, and in certain cases can be identified by the use of terms such as "may","will", "should", "expect","anticipate", "project", "estimate","intend", "continue", "target","believe" (or the negatives thereon) or other variations thereon or comparable terminology.
These forward-looking statements, as well as those included in any related materials, are subject to risks, uncertainties and assumptions about the Company and/or its underlying investments, including, among other things, the development of the applicable entity's business, trends in its operating industry, expected use of financing proceeds and future capital expenditures and acquisitions.
Considering these risks, uncertainties and assumptions, the events in the forward-looking statements may not occur.
The information contained in this announcement is given at the date of its publication (unless otherwise marked). No reliance may be placed for any purpose whatsoever on the information or opinions contained in this announcement or on its completeness, accuracy or fairness.
